Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Jaguar Health (JAGX) Revenue (2016 - 2025)

Historic Revenue for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to $3.1 million.

  • Jaguar Health's Revenue fell 80.44% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.8 million, marking a year-over-year increase of 1245.23%. This contributed to the annual value of $11.7 million for FY2024, which is 1975.21% up from last year.
  • Per Jaguar Health's latest filing, its Revenue stood at $3.1 million for Q3 2025, which was down 80.44% from $3.0 million recorded in Q2 2025.
  • In the past 5 years, Jaguar Health's Revenue ranged from a high of $3.5 million in Q4 2024 and a low of $385000.0 during Q2 2021
  • For the 5-year period, Jaguar Health's Revenue averaged around $2.4 million, with its median value being $2.7 million (2023).
  • As far as peak fluctuations go, Jaguar Health's Revenue plummeted by 8784.34% in 2021, and later skyrocketed by 65870.13% in 2022.
  • Over the past 5 years, Jaguar Health's Revenue (Quarter) stood at $2.1 million in 2021, then skyrocketed by 56.73% to $3.3 million in 2022, then decreased by 29.45% to $2.3 million in 2023, then surged by 52.57% to $3.5 million in 2024, then fell by 12.14% to $3.1 million in 2025.
  • Its Revenue stands at $3.1 million for Q3 2025, versus $3.0 million for Q2 2025 and $2.2 million for Q1 2025.